Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M404Revenue $M91.2Net Margin (%)17.1Z-Score7.6
Enterprise Value $M395EPS $0.4Operating Margin %10.0F-Score6
P/E(ttm))9.6Cash Flow Per Share $0.9Pre-tax Margin (%)10.2Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %0Quick Ratio2.2Cash flow > EarningsN
Price/Sales1.65-y EBITDA Growth Rate %-16.9Current Ratio4.3Lower Leverage y-yY
Price/Cash Flow17.6y-y EBITDA Growth Rate %-10.1ROA % (ttm)7.7Higher Current Ratio y-yY
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)9.5Less Shares Outstanding y-yN
Payout Ratio %51.0Shares Outstanding M23.1ROI % (ttm)10.1Gross Margin Increase y-yN

Gurus Latest Trades with TRIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TRIBJohn Keeley 2011-09-30 Sold Out -0.0026%$9.25 - $10.83
($10.16)
$ 17.4972%Sold Out0
TRIBJohn Keeley 2011-03-31 Add$8.3 - $9.88
($8.91)
$ 17.4996%Add 53.33%16,100
TRIBJohn Keeley 2010-12-31 Reduce$6.3 - $8.9
($7.74)
$ 17.49126%Reduce -34.38%10,500
TRIBJohn Keeley 2010-06-30 Add$5.49 - $6.49
($6.08)
$ 17.49188%Add 45.45%16,000
TRIBJohn Keeley 2010-03-31 Buy $3.84 - $5.74
($4.54)
$ 17.49285%New holding, 11000 sh.11,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TRIB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


TRIB: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TRIB :

    Quarterly/Annual Reports about TRIB:

      News about TRIB:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Trinity Biotech Announces CLIA waiver of Rapid Syphilis Test Dec 16 2014
      11:32 am Trinity Biotech announced that a CLIA waiver has been received for Syphilis Health Check, a... Dec 16 2014
      Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test Dec 16 2014
      Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% Oct 24 2014
      Trinity Biotech Announces Q3 2014 Financial Results Oct 23 2014
      Trinity Biotech Announces Quarter 3 Financial Results and Temporary Suspension of Meritas Troponin... Oct 23 2014
      Q3 2014 Trinity Biotech PLC Earnings Release - Time Not Supplied Oct 23 2014
      Trinity Biotech (TRIB) Downgraded From Buy to Hold Oct 16 2014
      Trinity Biotech plc to Announce Third Quarter Fiscal 2014 Financial Results Oct 06 2014
      Trinity Biotech Announces CE Marking of New Meritas Heart Failure (BNP) Point-of-Care Test Sep 25 2014
      [video] Close look at tax inversion motif Aug 22 2014
      Trinity Biotech upgraded to Buy from Neutral at Roth Capital Apr 30 2014
      Trinity Biotech upgraded to Buy from Neutral at Roth Capital Apr 30 2014
      Trinity Biotech's CEO Discusses Q1 2014 Results - Earnings Call Transcript Apr 29 2014
      TRINITY BIOTECH PLC Financials Apr 12 2014
      Trinity Biotech (TRIB) Falls: Stock Goes Down 5.4% Mar 25 2014
      OraSure Seems Too Cheap Relative To Infectious Disease Opportunities Mar 06 2014
      Trinity Biotech's CEO Discusses Q4 2013 Results - Earnings Call Transcript Mar 04 2014
      Trinity Biotech Getting A Head-Of-The-Class Multiple Jan 17 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK